BSE Live
Dec 05, 16:01Prev. Close
3801.65
Open Price
3813.95
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 05, 15:56Prev. Close
3795.70
Open Price
3805.10
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
3785.90 (356)
| Cash Flow of Torrent Pharmaceuticals (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 1,116.77 | 935.12 | 562.13 | 955.01 | 2,348.35 | |
| Net CashFlow From Operating Activities | 1,579.90 | 1,231.83 | 941.08 | 679.38 | 2,403.00 | |
| Net Cash Used In Investing Activities | 269.43 | -373.33 | -4,218.90 | -532.60 | -586.20 | |
| Net Cash Used From Financing Activities | -1,555.48 | -927.58 | 2,928.72 | -131.25 | -1,325.82 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 1.78 | |
| Net Inc/Dec In Cash And Cash Equivalents | 293.85 | -69.08 | -349.10 | 15.53 | 492.76 | |
| Cash And Cash Equivalents Begin of Year | 92.61 | 512.99 | 862.12 | 846.59 | 353.83 | |
| Cash And Cash Equivalents End Of Year | 386.46 | 443.91 | 513.02 | 862.12 | 846.59 |
14.11.2025
Torrent Pharma Consolidated September 2025 Net Sales at Rs 3,302.00 crore, up 14.3% Y-o-Y
12.11.2025
Torrent Pharma Standalone September 2025 Net Sales at Rs 2,762.00 crore, up 13.48% Y-o-Y
29.07.2025
Torrent Pharma Consolidated June 2025 Net Sales at Rs 3,178.00 crore, up 11.16% Y-o-Y
29.07.2025
Torrent Pharma Standalone June 2025 Net Sales at Rs 2,616.00 crore, up 7.3% Y-o-Y
12.07.2023
Torrent Pharma Q1 PAT may dip 9.7% YoY to Rs 319.7 cr: Nirmal Bang
17.01.2023
Torrent Pharma Q3 PAT seen up 28.9% YoY to Rs 3,211 cr: Nirmal Bang
13.07.2022
Torrent Pharma Q1 PAT seen up 2.8% YoY to Rs 339.1 cr: ICICI Direct
08.07.2022
Torrent Pharmaceuticals Q1 PAT seen up 1.4% YoY to Rs 334.5 cr: Prabhudas Lilladher
24.07.2019
Torrent Pharma shares jump 6% as brokerages remain bullish after Q1 show
25.08.2018
Pharma Q1 review: Brokerages say performance a mixed bag, but are upbeat on domestic biz
22.01.2014
14.01.2012